Inspire Medical Systems, Inc. to Present at Upcoming Investor Conferences

Rhea-AI Summary

Inspire Medical Systems, Inc. (NYSE: INSP), a medical technology company specializing in minimally invasive solutions for obstructive sleep apnea, has announced its participation in two upcoming investor conferences. The company will present at the Morgan Stanley 22nd Annual Global Healthcare Conference at 7:00 a.m. Eastern Time and the Wells Fargo 2024 Healthcare Conference at 3:00 p.m. Eastern Time, both on September 4, 2024.

Both presentations will be accessible via live webcasts, with links provided for each event. Replays of the presentations will be available for two weeks following the events in the Event Archive section of Inspire's Investor website at https://investors.inspiresleep.com.

News Market Reaction – INSP

-0.52%

1 alert

-0.52% News Effect

On the day this news was published, INSP declined 0.52%, reflecting a mild negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

MINNEAPOLIS, Aug. 21, 2024 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, announced today that its management team will present at the Morgan Stanley 22^nd Annual Global Healthcare Conference and the Wells Fargo 2024 Healthcare Conference on Wednesday, September 4, 2024.

Inspire is scheduled to present at the Morgan Stanley conference at 7:00 a.m. Eastern Time. The presentation will be accessible via a live webcast here.

Inspire is scheduled to present at the Wells Fargo conference at 3:00 p.m. Eastern Time. The presentation will be accessible via a live webcast here.

Webcast replays of the presentations will be available for two weeks following the presentations in the Event Archive section of Inspire’s Investor website at https://investors.inspiresleep.com.

About Inspire Medical Systems
Inspire is a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea. Inspire’s proprietary Inspire therapy is the first and only FDA-approved neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea.

For additional information about Inspire, please visit www.inspiresleep.com.

Investor and Media Contact
Ezgi Yagci
Vice President, Investor Relations
ezgiyagci@inspiresleep.com
617-549-2443

FAQ

When is Inspire Medical Systems (INSP) presenting at the Morgan Stanley Healthcare Conference?

Inspire Medical Systems (INSP) is presenting at the Morgan Stanley 22nd Annual Global Healthcare Conference on September 4, 2024, at 7:00 a.m. Eastern Time.

What time is Inspire Medical Systems (INSP) scheduled to present at the Wells Fargo Healthcare Conference?

Inspire Medical Systems (INSP) is scheduled to present at the Wells Fargo 2024 Healthcare Conference on September 4, 2024, at 3:00 p.m. Eastern Time.

How can investors access Inspire Medical Systems' (INSP) presentations at the upcoming conferences?

Investors can access Inspire Medical Systems' (INSP) presentations via live webcasts, with links provided for each event. Replays will be available for two weeks after the presentations on the company's investor website.

What is the main focus of Inspire Medical Systems (INSP)?

Inspire Medical Systems (INSP) is a medical technology company focused on developing and commercializing innovative, minimally invasive solutions for patients with obstructive sleep apnea.